naltrexone and Mast Cell Activation Disease

naltrexone has been researched along with Mast Cell Activation Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brook, JB; Goodman, B; Myers, TL; Weinstock, LB	1

Other Studies

1 other study(ies) available for naltrexone and Mast Cell Activation Disease

Article	Year
Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment. BMJ case reports, 2018, Jan-11, Volume: 2018 Topics: Adult; Anti-Bacterial Agents; Blind Loop Syndrome; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Intestine, Small; Mastocytosis; Naltrexone; Narcotic Antagonists; Postural Orthostatic Tachycardia Syndrome	2018

Article

Year

Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment.

BMJ case reports, 2018, Jan-11, Volume: 2018

Topics: Adult; Anti-Bacterial Agents; Blind Loop Syndrome; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Intestine, Small; Mastocytosis; Naltrexone; Narcotic Antagonists; Postural Orthostatic Tachycardia Syndrome

2018